Quality Control Department (Chemical Laboratory), Torrent Pharmaceuticals Ltd.


Also Listed In
Related Labs
Scope of Accrediation
Products

Accrediation valid upto
20-07-2021

About Quality Control Department (Chemical Laboratory), Torrent Pharmaceuticals Ltd.

Torrent Pharma, Torrent Group's flagship, is one of the country's leading pharmaceutical companies. Initiating the niche marketing concept in India, the company is a pioneer and today one of the leading cardiovascular (CV), central nervous (CNS), gastrointestinal (GI) and female healthcare (WHC) therapy industries. Also in diabetology, pain control, gynecology, oncology, and Antinfection sections, the company operates significantly. The competitive advantage of Torrent Pharma lies in the world-class production, sophisticated R&D, a large national network and broad worldwide participation across more than 40 nations. The company has a worldwide presence. Torrent has been reinforced on the Indian pharmaceutical industry by acquiring Elder Pharma's branded Indian company in 2013 and Zyg Pharma's Dermaceutics company in 2015, Glochem Industries API plant in 2016, Novartis ' women's health brands and Unichem's Indian branded company, as well as Sikkim's plant in 2017. With the 90-year-old Heumann from Pfizer, Torrent Pharma began international purchases in 2005 to join the German market. ANDA was subsequently bought from Ranbaxy for the United States Market in 2015. By effectively applying the idea of niche marketing, Torrent Pharma has created a fresh path in the Indian Pharmaceutical industry. The niche marketing idea we were pioneering today is among the leading cardiovascular (CV), central nervous (CNS), gastrointestinal (GI) and female healthcare (WHC) sector therapeutics. The idea is a pioneering project. In the diabetology, pain management, gynecology, oncology, and anti-infective sections, the company is also significantly involved. Torrent Pharma also has a powerful global presence in 40 nations, including the USA, Europe, Brazil and the rest of the world, which operate under controlled and emerging markets. The company operates in 12 different jurisdictions in Brazil, Germany, and the U.S. through its wholly-owned subsidiaries.